Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Fiasp® on Glycaemic Control in a Real World Population With Type 1 Diabetes Mellitus Using Flash Glucose Monitoring

NCT03450863 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT03450863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03450863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Fiasp® on Glycaemic Control in a Real World Population With Type 1 Diabetes Mellitus Using Flash Glucose Monitoring
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
March 22, 2018
Completion date
September 4, 2019
Enrollment
320 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1 diabetes